Non-pharmacological intervention for gastro-oesophageal reflux disease in primary care

British Journal of General Practice

Volumn 60, Issue 581, 2010, Pages

  Dibley, Lesley B ^a   Norton, Christine ^a   Jones, Roger ^b  

^a BUCKINGHAMSHIRE NEW UNIVERSITY   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Gastro oesophageal reflux disease; Patient education; Primary care; Self management

Indexed keywords

MEPRADEC; OMEPRAZOLE; PROTON PUMP INHIBITOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BEHAVIOR CHANGE; COMPREHENSION; CONTROL; EATING HABIT; EDUCATION PROGRAM; FEMALE; GASTROESOPHAGEAL REFLUX; GENERAL CONDITION IMPROVEMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT EDUCATION; PERCEPTION; PRIMARY MEDICAL CARE; SELF CARE; STRESS; SYMPTOM; TREATMENT OUTCOME; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GASTROESOPHAGEAL REFLUX; GENERAL PRACTICE; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; QUESTIONNAIRES; SELF CARE; TREATMENT OUTCOME;

EID: 78650558317     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: 10.3399/bjgp10X544050     Document Type: Article

References (27)

1. Dent J, El-Serag H, Wallander M, Johansson S. Epidemiology of gastro-oesophageal reflux discase: a systematic review. Gut 2005; 54(5): 710-717. (Pubitemid 40559260)
2. Shapiro M, Moore A, Fass R. What to do when doubling the dosage isn't enough -refractory gastroesophageal reflux disease -what next? ; Respir Dis 2007; 28: 427-434.
3. Health and Social Care Information Centre. Prescription cost analysis for England 2007. London: Government Statistical Service, 2008.
4. Health and Social Care Information Centre. Prescription cost analysis for England 2008. London: Government Statistical Service, 2009.
5. North of England Dyspepsia Guideline Development Group. Dyspepsia: managing dyspepsia in adults in primary care. Report No. 112. Newcastle: University of Newcastle, 2004.
6. Mason J, Hungin A. Review article: gastro-oesophageal reflux disease - the health economic implications. Aliment Pharmacol Ther 2005; 22(suppl1): 20-31. (Pubitemid 41153076)
7. Raghunath A, O'Morain C, McLoughlin R. Review article: the longterm use of proton-pump inhibitors. Aliment Pharmacol Ther 2005; 22(suppl1): 55-63. (Pubitemid 41153080)
8. Dibley L, Norton C, Jones R. Is there a role for lifestyle education in the management of gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol 2009; 21 (11): 1229-1240.
9. Hungin A, Hill C, Raghunath A. Systematic review: frequency and reasons for consultation for gastro-ocsophagcal reflux disease and dyspepsia. Aliment Pharmacol Ther 2009; 30(4): 331-342.
10. National Institute for Health and Clinical Excellence. Dyspepsia - management of dyspepsia in adults in primary care. London: NICE, 2004.
11. Barlow J, Wright C, Sheasby J, et al. Self-management approaches for people with chronic conditions: a review. Patient Educ Couns 2002; 48(2): 177-187. (Pubitemid 36158880)
12. Robinson A, Lee V, Kennedy A, et al. A randomised controlled trial of self-help interventions in patients with a primary care diagnosis of irritable bowel syndrome. Gut 2006; 55(643): 648.
13. Whorwell P. Hypnotherapy for irritable bowel syndrome: the response of colonic and non-colonic symptoms. J Psychosotn Res 2008; 64(6): 621-623.
14. Kennedy T, Jones R, Darnley S, et al. Cognitive behaviour therapy in addition to antispasmodic treatment for irritable bowel syndrome in primary care: a randomised controlled trial. BMJ 2005; 331 (7514): 435-437. (Pubitemid 41176381)
15. Dibley L, Norton C, Jones R. Don't eat tomatoes: patient's selfreported experiences of causes of symptoms in gastro-oesophageal reflux disease. Fam Pract 2010; 27(4): 410-417.
16. Dibley L, Norton C, Jones R. Informing a patient education programme for GORD: a literature review. Gastrointest Nurs 2009; 7(5): 28-37.
17. Lorig K. Patient education: a practical approach. 3rd edn. Thousand Oaks, CA: Sage Publications, Inc, 2001.
18. Abraham C, Kelly M, West R, Michie S. The UK national institute for health and clinical excellence public health guidance on behaviour change: a brief introduction. Psychol Health Med 2009; 14(1): 1-8.
19. Broadbent E, Petrie K, Main J, Weinman J. The Brief Illness Perception Questionnaire. J Psychosm Res 2006; 60(631): 637.
20. Jones R, Coyne K, Wiklund I. The Gastro-Oesophagcal Reflux Disease Impact Scale: a patient management tool for primary care. Aliment Pharmacol Ther 2007; 25(12): 1451-1459. (Pubitemid 46848895)
21. Zigmund A, Snaith R. The Hospital Anxiety and Depression Scale. Acia Psychiatr Scand 1983; 67(6): 361-370.
22. Bandura A. Self-efficacy mechanism in human agency. Am Psychol 1982; 37(2): 122-147.
23. Urnes J, Petersen H, Farup P. Patient education in gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol 2008; 19(12): 1104-1110.
24. Urnes J, Petersen H, Farup P. Disease knowledge after an educational program in patients with GERD -a randomized controlled trial. BMC Health Serv Res 2008; 8: 236.
25. Reimer C, Søndergaard B, Hilsted L, Bytzer P. Proton pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy. Gastroenterology 2009; 137(1): 80-87.
26. Liker H, Ducrotté P, Malfertheiner P, Unmet medical needs among patients with gastroesophageal reflux disease: a foundation for improving management in primary care. Dig Dis 2009; 27(1): 62-67.
27. Van Marrewijk CJ, Mujakovic S, et al. Effect and cost-effectiveness of step-up versus step-down treatment with antacids, H2-receptor antagonists, and proton pump inhibitors in patients with new onset dyspepsia (DIAMOND study): a primary-care-based randomised controlled trial. Lancet 2009; 373(9659): 215-225.